Medicare Enrolled
Dr. Susan Glover, M.D.
Urology Physician · Springfield, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Glover from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glover?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Glover
Dr. Susan Glover is an urology physician in Springfield, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Glover performed 17,071 Medicare services across 4,085 unique beneficiaries.
Between the years covered by Open Payments, Dr. Glover received a total of $2,013 from 23 pharmaceutical and/or device companies across 49 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Glover is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in MA
$2,013 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,071
Medicare services
Top 2% in MA for urology physician
4,085
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~854 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
10,400 | $5 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
865 | $65 | $250 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
845 | $34 | $60 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
728 | $2 | $15 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
654 | $3 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
479 | $96 | $337 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
427 | $8 | $25 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
382 | $8 | $100 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
377 | $50 | $200 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
330 | $34 | $75 |
| Catheter specimen collection A procedure to collect a specimen using a catheter. This service is available in all places of service. |
229 | $8 | $25 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
198 | $68 | $350 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
136 | $196 | $750 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
129 | $40 | $135 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
78 | $57 | $300 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
74 | $325 | $650 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
73 | $122 | $400 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
66 | $33 | $75 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
66 | $34 | $75 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
64 | $34 | $70 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
64 | $34 | $54 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
54 | $25 | $180 |
| Manual urine cell examination A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells. |
49 | $496 | $1,600 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
45 | $89 | $250 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
31 | $20 | $60 |
| Complicated insertion of bladder tube | 29 | $102 | $525 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
27 | $9 | $180 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
22 | $57 | $500 |
| Insertion of temporary bladder tube | 22 | $36 | $180 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
19 | $45 | $190 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
19 | $96 | $884 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
17 | $8 | $25 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
17 | $335 | $1,200 |
| Simple change of bladder tube | 16 | $67 | $350 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
15 | $56 | $650 |
| Radiologist review of ureter or urethra image A radiologist reviews images of the ureter or urethra to evaluate the structures. |
13 | $32 | $65 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
12 | $13 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
64.2% medium
33.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,013
Total received (2018-2024)
Avg $288/year across 7 years
Top 44% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
49
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,640 (81.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$373 (18.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$449
2023
$287
2022
$325
2021
$432
2020
$18
2019
$124
2018
$378
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Tempus AI, Inc
$129
ABBVIE INC.
$127
Ferring Pharmaceuticals Inc.
$41
Endo Pharmaceuticals Inc.
$39
COLOPLAST CORP
$36
180 Medical, Inc.
$29
UROGEN PHARMA, INC.
$25
Sumitomo Pharma America, Inc.
$23
Top 3 companies account for 66.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$300
AbbVie, Inc.
$212
ABBVIE INC.
$190
Boston Scientific Corporation
$155
PROCEPT BioRobotics Corporation
$133
Palette Life Sciences, Inc.
$130
Tempus AI, Inc
$129
Dornier MedTech America, Inc
$127
Allergan Inc.
$105
180 Medical, Inc.
$86
Endo Pharmaceuticals Inc.
$75
Laborie Medical Technologies Corp.
$60
Ferring Pharmaceuticals Inc.
$41
Agiliti Surgical, Inc.
$39
COLOPLAST CORP
$36
PFIZER INC.
$29
Myovant Sciences Inc.
$26
UROGEN PHARMA, INC.
$25
Allergan, Inc.
$25
Sumitomo Pharma America, Inc.
$23
Axonics, Inc.
$23
Coloplast Corp
$22
Merck Sharp & Dohme LLC
$22
Top 3 companies account for 34.9% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AVEED · Axonics · BOTOX · BOTOX - UROLOGY · CURE CATHETER · Dornier MedTech · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · JELMYTO · KEYTRUDA · LITHOVUE · Luja Coude · Lupron · Lupron Depot · Myrbetriq · ORGOVYX · Sonablate · SpeediCath · XIAFLEX · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
36
Per 100K population
7.8
County median income
$70,535
Nearest hospital
MERCY MEDICAL CTR
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Glover is a mixed practice specialist, with above-average Medicare volume (top 2% in MA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Glover experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Glover performed 10,400 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Glover receive payments from pharmaceutical companies?
Yes. Dr. Glover received a total of $2,013 from 23 companies across 49 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Glover's costs compare to other urology physicians in Springfield?
Dr. Glover's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Glover) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Springfield
Browse urology physicians in Springfield ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology